Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat

American Journal of Pathology

Volumn 162, Issue 6, 2003, Pages 2079-2090

  Nath, Karl A ^a   Kanakiriya, Sharan K R ^a   Grande, Joseph P ^a   Croatt, Anthony J ^a   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ENDOTHELIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEMODIALYSIS; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VEIN BYPASS;

EID: 0038184151     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64339-8     Document Type: Article

References (67)

1. Fairbairn II JF, Bernatz PE: Arteriovenous fistulas. Peripheral Vascular Diseases, Ed 4. Edited by JF Fairbairn, II, JL Juergens, J Spittell Philadelphia, W. B. Saunders, Co., 1972, pp 303-326
2. Winaver J, Hoffman A, Burnett Jr JC, Haramati A: Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988, 254:R776-R784
3. Wilkins MR, Settle SL, Stockmann PT, Needleman P: Maximizing the natriuretic effects of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci USA 1990, 87:6465-6469
4. Huang M, Hester RL, Guyton AC, Norman Jr RA: Hemodynamic studies in DOCA-salt hypertensive rats after opening of an arteriovenous fistula. Am J Physiol 1992, 262:H1802-H1808
5. Pieruzzi F, Abassi ZA, Keiser HR: Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 1995, 92:3105-3112
6. Kirk JE, Wilkins MR: Renal effects of concurrent E-24.11 and ACE inhibition in the aorto-venocaval fistula rat. Br J Pharmacol 1996, 119:943-948
7. Wegner M, Hirth-Dietrich C, Stasch J-P: Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Cardiovasc Res 1996, 31:891-898
8. Abassi ZA, Gurbanov K, Mulroney SE, Potlog C, Opgenorth TJ, Hoffman A, Haramati A, Winaver J: Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure. Circulation 1997, 96:3655-3664
9. Garcia R, Diebold S: Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990, 24:430-432
10. Ruzicka M, Keeley FW, Leenen FHH: The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin. Circulation 1994, 90:1989-1996
11. Brower GL, Henegar JR, Janicki JS: Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol 1996, 271:H2071-H2078
12. Norling LL, Thornhill BA, Chevalier RL: Abnormal glomerular response to atrial natriuretic peptide in rats with aortocaval fistulas. J Am Soc Nephrol 1996, 7:1038-1044
13. Namba T, Tsutsui H, Tagawa H, Takahashi M, Saito K, Kozai T, Usui M, Imanaka-Yoshida K, Imaizumi T, Takeshita A: Regulation of fibrillar collagen gene expression and protein accumulation volume-overloaded cardiac hypertrophy. Circulation 1997, 95:2448-2454
14. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, Winaver J: Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 2000, 102:1315-1322
15. Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998, 97: 916-931
16. Loscalzo J: Vascular matrix and vein graft failure. Is the message in the medium? Circulation 2000, 101:221-223
17. Newby AC, Zaltsman AB: Molecular mechanisms in intimal hyperplasia. J Pathol 2000, 190:300-309
18. Sukhatme VP: Vascular access stenosis: prospects for prevention and therapy. Kidney Int 1996, 49:1161-1174
19. Hakim R, Himmelfarb J: Hemodialysis access failure: a call to action. Kidney Int 1998, 54:1029-1040
20. Schwab SJ: Vascular access for hemodialysis. Kidney Int 1999, 55: 2078-2090
21. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2001, 2:108-115
22. Schmidt AM, Stern DM: Chemolkines on the rise. MCP-1 and restenosis. Arterioscler Thromb Vasc Biol 2001, 21:297-299
23. Shin WS, Szuba A, Rockson SG: The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002, 160:91-102
24. Ikeda U, Matsui K, Murakami Y, Shimada K: Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 2002, 25:143-147
25. Huber K, Christ G, Wojta J, Gulba D: Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thromb Res 2001, 103:S7-S19
26. Binder BR, Christ G, Gruber F, Grubic N, Hufnagl P, Krebs M, Mihaly J, Prager GW: Plasminogen activator inhibitor 1: physiological and pathophysiological roles. New Physiol Sci 2002, 17:56-61
27. Miyauchi T, Masaki T: Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999, 61:391-415
28. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292
29. Nath KA, Grande JP, Croatt AJ, Haugen JD, Kim Y, Rosenberg ME: Redox regulation of renal DNA synthesis, transforming growth factor-β1 and collagen gene expression. Kidney Int 1998, 53:367-381
30. Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H: Intracellular targets in heme protein induced renal injury. Kidney Int 1998, 53:100-111
31. Nath KA, Croatt AJ, Haggard JJ, Grande JP: Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 2000, 57:2423-2433
32. Grande JP, Walker HJ, Holub BJ, Warner GM, Keller DM, Haugen JD, Donadio Jr JV, Dousa TP: Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 2000, 57:1027-1040
33. Radford Jr MG, Donadio Jr JV, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997, 8:199-207
34. Braddock M, Schwachtgen J-L, Houston P, Dickson MC, Lee MJ, Campbell CJ: Fluid shear stress modulation of gene expression in endothelial cells. News Physiol Sci 1998, 13:241-246
35. Brooks AR, Lelkes PI, Rubanyi GM: Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genom 2002, 9:27-41
36. Dekker RJ, Van Soest S, Fontijn RD, Salamanca S, De Groot PG, VanBavel E, Pannekoek H, Horrevoets AJ: Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002, 100:1689-1698
37. Riser BL, Cortes P, Yee J: Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000, 9:43-47
38. O'Callaghan CJ, Williams B: Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells. Hypertension 2000, 36:319-324
39. Negishi M, Lu D, Zhang YQ, Sawada Y, Sasaki T, Kayo T, Ando J, Izumi T, Kurabayashi M, Kojima I, Masuda H, Takeuchi T: Upregulatory expression of furin and transforming growth factor-β by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2001, 21:785-790
40. Tedgui A, Mallat Z: Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001, 88:877-887
41. Porter KE, Loftus IM, Peterson M, Bell PRF, London NJM, Thompson MM: Marimastat inhibits neointimal thickening in a model of human vein graft stenosis. Br J Surg 1998, 85:1373-1377
42. Castronuovo Jr JJ, Price RM: The sequence of gene expression in cultured human saphenous vein after injury. J Vasc Surg 2002, 35: 146-151
43. Hoch JR, Stark VK, Hullett DA, Turnipseed WD: Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994, 116:463-471
44. Stark VK, Warner TF, Hoch JR: An ultrastructural study of progressive intimal hyperplasia in rat vein grafts. J Vasc Surg 1997, 26:94-103
45. Faries PL, Marin ML, Veith FJ, Ramierez JA, Suggs WD, Parsons RE, Sanchez LA, Lyon RT: Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg 1996, 24:463-471
46. Meguro T, Nakashima H, Kawada S, Tokunaga K, Ohmoto T: Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts. Neurosurgery 2000, 46:963-970
47. O'Brien Jr JE, Shi Y, Fard A, Bauer T, Zalewski A, Mannion JD: Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 1997, 114:38-45
48. Shi Y, O'Brien Jr JE, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A: Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997, 95:2684-2693
49. Landis ME, Ray EC, Gloviczki P, Miller VM: Effects of dietary L-arginine on structure and function of flow-restricted vein grafts. J Vasc Surg 2001, 33:829-839
50. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993, 43:1091-1096
51. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996, 7:523-535
52. US Renal Data System: 1997 Annual Data Report: The Economic Cost of ESRD, Vascular Access Procedures, and Medicare Spending for Alternative Modalities of Treatment, Chapter X. 1997, pp 143-161
53. Swedberg SH, Brown BG, Sigley R, Wright TN, Gordon D, Nicholls SC: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989, 80: 1726-1736
54. Rekhter M, Nicholls S, Ferguson M, Gordon D: Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscl Thromb 1993, 13:609-617
55. Hofstra L, Tordoir JHM, Kitslaar PJEHM, Hoeks APG, Daemen MJAP: Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters? Circulation 1996, 94:1283-1290
56. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001, 59:2325-2334
57. Wilkie ME, Khandan-Nia N, Ghatei MA, Bloom SR, Raftery MJ, Cunningham J: Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1 release? Nephrol Dial Transplant 1992, 7:1019-1021
58. De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E: Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 1996, 7:1169-1177
59. De Marchi S, Cecchin E, Falleti E, Giacomello R, Stel G, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E: Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients. J Am Soc Nephrol 1997, 8:1147-1156
60. Weiss MF, Scivittaro V, Anderson JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001, 37:970-981
61. Stracke S, Konner K, Kostlin I, Friedl R, Jehle PM, Hombach V, Keller F, Waltenberger J: Increased expression of TGF-β1 and IGF-1 in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 2002, 61:1011-1019
62. Johnson MS, McLennan G, Lalka SG, Whitfield RM, Dreesen RG: The porcine hemodialysis access model. J Vasc Interv Radiol 2001, 12: 969-977
63. Kohler TR, Kirkman TR: Dialysis access failure: a sheep model of rapid stenosis. J Vasc Surg 1999, 30:744-751
64. Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P: Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 2002, 62:2272-2280
65. Brower GL, Janicki JS: Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol 2001, 280:H674-H683
66. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000, 35:S117-S131.
67. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000, 36:S24-S30